These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 25338624)

  • 1. Treatment in canine epilepsy--a systematic review.
    Charalambous M; Brodbelt D; Volk HA
    BMC Vet Res; 2014 Oct; 10():257. PubMed ID: 25338624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiepileptic drugs' tolerability and safety--a systematic review and meta-analysis of adverse effects in dogs.
    Charalambous M; Shivapour SK; Brodbelt DC; Volk HA
    BMC Vet Res; 2016 May; 12():79. PubMed ID: 27206489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review of antiepileptic drugs' safety and effectiveness in feline epilepsy.
    Charalambous M; Pakozdy A; Bhatti SFM; Volk HA
    BMC Vet Res; 2018 Mar; 14(1):64. PubMed ID: 29499762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenobarbital or potassium bromide as an add-on antiepileptic drug for the management of canine idiopathic epilepsy refractory to imepitoin.
    Royaux E; Van Ham L; Broeckx BJ; Van Soens I; Gielen I; Deforce D; Bhatti SF
    Vet J; 2017 Feb; 220():51-54. PubMed ID: 28190495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the potential of the anti-epileptic drug imepitoin as a treatment for co-morbid anxiety in dogs with idiopathic epilepsy.
    Packer RM; De Risio L; Volk HA
    BMC Vet Res; 2017 Apr; 13(1):90. PubMed ID: 28388948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imepitoin withdrawal in dogs with idiopathic epilepsy well-controlled with imepitoin and phenobarbital and/or potassium bromide does not increase seizure frequency.
    Stee K; Martlé V; Broeckx BJG; Royaux E; Van Ham L; Bhatti SFM
    Vet J; 2017 Dec; 230():1-5. PubMed ID: 29208209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
    Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
    Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of a combination therapy of imepitoin with phenobarbital in dogs with refractory idiopathic epilepsy.
    Neßler J; Rundfeldt C; Löscher W; Kostic D; Keefe T; Tipold A
    BMC Vet Res; 2017 Jan; 13(1):33. PubMed ID: 28118828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy and safety of imepitoin in comparison with phenobarbital for the control of idiopathic epilepsy in dogs.
    Tipold A; Keefe TJ; Löscher W; Rundfeldt C; de Vries F
    J Vet Pharmacol Ther; 2015 Apr; 38(2):160-8. PubMed ID: 25079881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daytime and nocturnal activity in treated dogs with idiopathic epilepsy compared to matched unaffected controls.
    Barry M; Cameron S; Kent S; Barnes-Heller H; Grady K
    J Vet Intern Med; 2021 Jul; 35(4):1826-1833. PubMed ID: 34223667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of systemic antimicrobial treatment in canine superficial and deep pyoderma: a systematic review.
    Summers JF; Brodbelt DC; Forsythe PJ; Loeffler A; Hendricks A
    Vet Dermatol; 2012 Aug; 23(4):305-29, e61. PubMed ID: 22734856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-blinded phenobarbital-controlled trial of levetiracetam as mono-therapy in dogs with newly diagnosed epilepsy.
    Fredsø N; Sabers A; Toft N; Møller A; Berendt M
    Vet J; 2016 Feb; 208():44-9. PubMed ID: 26639829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of levetiracetam as adjunctive treatment for refractory canine epilepsy: a randomized, placebo-controlled, crossover trial.
    Muñana KR; Thomas WB; Inzana KD; Nettifee-Osborne JA; McLucas KJ; Olby NJ; Mariani CJ; Early PJ
    J Vet Intern Med; 2012; 26(2):341-8. PubMed ID: 22295869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing the effects of first-line antiepileptic drugs on the gait of dogs with idiopathic epilepsy.
    Suiter EJ; Packer RM; Volk HA
    Vet Rec; 2016 Jun; 178(26):652. PubMed ID: 27302918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of phenobarbital with bromide as a first-choice antiepileptic drug for treatment of epilepsy in dogs.
    Boothe DM; Dewey C; Carpenter DM
    J Am Vet Med Assoc; 2012 May; 240(9):1073-83. PubMed ID: 22515627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, safety, and tolerability of imepitoin in dogs with newly diagnosed epilepsy in a randomized controlled clinical study with long-term follow up.
    Rundfeldt C; Tipold A; Löscher W
    BMC Vet Res; 2015 Sep; 11():228. PubMed ID: 26330063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment into the usage of levetiracetam in a canine epilepsy clinic.
    Packer RM; Nye G; Porter SE; Volk HA
    BMC Vet Res; 2015 Feb; 11():25. PubMed ID: 25889090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiepileptic drugs as prophylaxis for postcraniotomy seizures.
    Greenhalgh J; Weston J; Dundar Y; Nevitt SJ; Marson AG
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD007286. PubMed ID: 32343399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placebo effect in canine epilepsy trials.
    Muñana KR; Zhang D; Patterson EE
    J Vet Intern Med; 2010; 24(1):166-70. PubMed ID: 19912522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of epilepsy of unknown origin in the Rottweiler breed.
    Heske L; Körberg IB; Nødtvedt A; Jäderlund KH
    Acta Vet Scand; 2015 Nov; 57():75. PubMed ID: 26546467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.